stockrow
Friday 6 November 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
76.26
5.83
+8.28%
Follow TEM
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
9.84 | 7.28 | 5.93 | 8.09 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
1,611.26 | (1,385.06) | (110.39) | (279.72) | |
P/B ratio |
29.67 | 23.43 | 19.43 | 20.94 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
10.31 | 7.66 | 6.37 | 8.47 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(143.60) | (46.19) | (46.75) | (49.41) | |
EV/FCF |
(103.32) | (40.18) | (39.52) | (43.92) | |
Quick Ratio |
2.33 | 3.01 | 2.98 | 2.86 | |
Current Ratio |
2.61 | 3.30 | 3.31 | 3.13 | |
Net Debt/EBITDA |
(24.87) | (11.31) | (10.42) | (14.71) | |
Debt/Assets |
55.10% | 57.51% | 57.76% | 54.49% | |
Debt/Equity |
2.70 | 3.06 | 2.96 | 2.52 | |
Asset Turnover |
0.64 | 0.72 | 0.74 | 0.79 | |
Operating CF/Net income |
(0.62) | (1.33) | 0.58 | 0.68 | |
Capex/Depreciation |
(0.52) | (0.40) | (0.36) | (0.22) | |
Interest Coverage |
(8.49) | (7.38) | (5.91) | (4.02) | |
Research and Development Expense of Revenue |
22.28% | 25.25% | 27.05% | 24.68% | |
Selling, General and Administrative Expense of Revenue |
56.34% | 59.05% | 61.07% | 56.78% | |
Intangible Assets out of Total Assets |
0.32 | 0.33 | 0.38 | 0.36 | |
Share Based Compensation of Revenue |
11.68% | 14.15% | 15.14% | 12.35% | |
Graham Net Nets |
(0.05) | (0.06) | (0.08) | (0.06) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.28%) | (2.47%) | (3.78%) | (2.39%) | |
Free Cash Flow Yield |
(1.01%) | (2.62%) | (2.72%) | (2.38%) | |
Revenue per Share |
2.27 | 2.13 | 1.95 | 2.11 | |
Operating CF per Share |
0.05 | (0.04) | (0.41) | (0.21) | |
Capex per Share |
(0.08) | (0.06) | (0.06) | (0.04) | |
Free Cash Flow per Share |
(0.03) | (0.10) | (0.47) | (0.25) | |
Cash per Share |
3.52 | 4.54 | 3.57 | 4.33 | |
Shareholders Equity per Share |
2.76 | 2.47 | 2.33 | 2.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.76 | 2.47 | 2.33 | 2.82 | |
Free Cash Flow |
(5.54) | (18.62) | (83.34) | (43.12) | |
Working Capital |
700.47 | 899.37 | 735.99 | 794.79 | |
Capital Expenditures |
(14.76) | (11.09) | (10.07) | (6.34) | |
Net Current Asset Value |
(814.32) | (630.11) | (664.74) | (616.34) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
332.19 | 313.60 | 285.61 | 232.99 | |
Average Payables |
65.03 | 76.57 | 64.88 | 67.90 | |
Average Inventory |
54.37 | 50.56 | 51.16 | 45.06 | |
Average Assets |
2,366.51 | 1,995.64 | 1,839.11 | 1,600.48 | |
Average Common Equity |
504.11 | 377.25 | 371.30 | 273.83 |
Columns are period end dates · fundamentals updated 5 Nov 2026